William Seton
About William Seton
William Seton is the Director of New Product Development at Teleflex Incorporated in Wyomissing, Pennsylvania, with extensive experience in leading cross-functional teams for in vitro diagnostic product development.
Current Title and Role
William Seton is the Director of New Product Development at Teleflex Incorporated located in Wyomissing, Pennsylvania, United States. In his role, he is responsible for overseeing the creation and implementation of new medical product initiatives and innovations within the company.
Professional Background
William Seton has held various high-level positions throughout his career. He worked as the Director and Project Leader at Ortho Clinical Diagnostics from 2015 to 2019, in the Rochester, New York area. Prior to that, he served as Director of System Development at Abbott Molecular from 2012 to 2015 in Des Plaines, Illinois. He also held the role of Director of Portfolio and Project Leadership at Novartis, Molecular Diagnostics from 2009 to 2012.
Early Career Experience
William Seton began his career at Honeywell as an Electrical Engineer in the Industrial Programmable Controller Division, serving from 1986 to 1990. He then moved to BD Diagnostic Instrument Systems as a Senior Engineer from 1990 to 1993 and subsequently served as Project Engineer at BD Primary Care Division from 1993 to 1996. Seton continued his career at BD Microbiology Systems as Project Engineer from 1996 to 2000 and then as Program Manager at Becton Dickinson from 2000 to 2008.
Educational Qualifications
William Seton holds a Master of Business Administration (MBA) in Business Administration from Penn State University, which he completed from 1997 to 1999. He also earned a Master of Engineering Science from Penn State University between 1986 and 1990. Additionally, he holds a Bachelor of Science in Electrical Engineering Technology from the University of Pittsburgh, which he achieved from 1982 to 1986.
Achievements in Product Development
Throughout his career, William Seton has successfully led the development of 10 FDA-cleared products. He has managed global product launches across over 30 countries and directed the worldwide launch of a high-volume molecular diagnostic platform. Additionally, he has led the development of eight real-time amplified assays and launched a molecular diagnostic sample collection, transport, and stabilization system. Seton has also developed 10 diagnostic instrument platforms and utilized Design for Six Sigma tools in new product development.
Expertise in In Vitro Diagnostics
William Seton brings extensive experience in leading cross-functional teams focused on in vitro diagnostic product development. His expertise includes directing the creation and execution of diagnostic instrument platforms and assay developments that meet regulatory standards, thus ensuring successful product launches globally.